R&D Pipeline

Guided by innovation and internationalization, Fosun Pharma increases its investment in R&D and the introduction of scientific research personnel, enriches its innovative product pipelines, improves its R&D and clinical trial capacities for new drugs, and speeds up the R&D and transformation of innovative technologies and products through diverse and multi-level cooperation models, such as independent R&D, co-development, in-licensing, and in-depth incubation.

Major Drug Projects under Development

As of December 31, 2021, Fosun Pharma had more than 240 projects under development, including innovator drugs, biosimilars, generic drugs and consistency evaluation.

  • 27
    Self-developed small molecule innovator drugs
  • 26
    Self-developed Innovative Biologics
  • 11
    Licensed-in innovator drugs
  • 14
    Self-developed biosimilars
  • 25
    Consistency Evaluation Projects